Mauritius will receive a consignment of Covaxin, India’s indigenously developed COVID-19 vaccine, on Friday, announced the High Commission of India in Port Louis on Thursday.Taking to Twitter, the High Commission said that India stands strong with Mauritius in the tough times, describing it as ‘a time-tested and enduring partnership’.”Mauritius arms itself with COVAXIN, India’s indigenously developed vaccine, in its fight against COVID19. India stands strong with Mauritius in these tough times. Consignment to arrive tomorrow. A time-tested and enduring partnership,” tweeted India in Mauritius.The Indian High Commission in Mauritius also said that Covaxin is effective against the UK variant and other heterologous strains.”Developed & manufactured by @BharatBiotech, COVAXIN has demonstrated 81% interim efficacy in preventing COVID19. COVAXIN is effective against UK variant strain & other heterologous strains. EUA received in 8 countries till date, 20 more to follow,” it saidMauritius will receive a consignment of Covaxin, India’s indigenously developed COVID-19 vaccine, on Friday, announced the High Commission of India in Port Louis on Thursday.Taking to Twitter, the High Commission said that India stands strong with Mauritius in the tough times, describing it as ‘a time-tested and enduring partnership’.”Mauritius arms itself with COVAXIN, India’s indigenously developed vaccine, in its fight against COVID19. India stands strong with Mauritius in these tough times. Consignment to arrive tomorrow. A time-tested and enduring partnership,” tweeted India in Mauritius.The Indian High Commission in Mauritius also said that Covaxin is effective against the UK variant and other heterologous strains.”Developed & manufactured by @BharatBiotech, COVAXIN has demonstrated 81% interim efficacy in preventing COVID19. COVAXIN is effective against UK variant strain & other heterologous strains. EUA received in 8 countries till date, 20 more to follow,” it saidRead More